| Clinical pharmacokinetics and pharmacodynamics of cefepime GM Pais, J Chang, EF Barreto, G Stitt, KJ Downes, MH Alshaer, E Lesnicki, ... Clinical pharmacokinetics 61 (7), 929-953, 2022 | 51 | 2022 |
| Glomerular function and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model J Chang, GM Pais, K Valdez, S Marianski, EF Barreto, MH Scheetz Antimicrobial Agents and Chemotherapy 66 (3), e02132-21, 2022 | 26 | 2022 |
| Cefazolin in the treatment of central nervous system infections: a narrative review and recommendation K Antosz, S Battle, J Chang, MH Scheetz, M Al‐Hasan, PB Bookstaver Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (1 …, 2023 | 21 | 2023 |
| High‐performance liquid chromatography method for rich pharmacokinetic sampling schemes in translational rat toxicity models with vancomycin MD Joshi, JN O'Donnell, N Venkatesan, J Chang, H Nguyen, NJ Rhodes, ... Clinical and Translational Science 10 (6), 496-502, 2017 | 15 | 2017 |
| Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy EF Barreto, J Chang, MW Bjergum, O Gajic, PJ Jannetto, KC Mara, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (11 …, 2023 | 9 | 2023 |
| A translational rat model to assess glomerular function changes with vancomycin GM Pais, J Chang, J Liu, MH Scheetz International journal of antimicrobial agents 59 (5), 106583, 2022 | 9 | 2022 |
| Urinary metabolomics from a dose-fractionated polymyxin B rat model of acute kidney injury E Locci, J Liu, GM Pais, A Chighine, DA Kahnamoei, T Xanthos, ... International Journal of Antimicrobial Agents 60 (1), 106593, 2022 | 7 | 2022 |
| Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model MD Joshi, GM Pais, J Chang, K Hlukhenka, SN Avedissian, A Gulati, ... Antimicrobial Agents and Chemotherapy 63 (10), 10.1128/aac. 00761-19, 2019 | 6 | 2019 |
| Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults EF Barreto, J Chang, AD Rule, KC Mara, LA Meade, J Paul, PJ Jannetto, ... Critical Care Explorations 5 (12), e1011, 2023 | 5 | 2023 |
| Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model GM Pais, S Marianski, K Valdez, RP Melicor, J Liu, R Rohani, J Chang, ... British Journal of Pharmacology 181 (5), 670-680, 2024 | 4 | 2024 |
| Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents J Chang, A Tasellari, JL Wagner, MH Scheetz Expert Review of Anti-infective Therapy 21 (12), 1309-1325, 2023 | 4 | 2023 |
| Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations EF Barreto, J Chang, AD Rule, KC Mara, LA Meade, J Paul, PJ Jannetto, ... Antimicrobial Agents and Chemotherapy 67 (11), e00810-23, 2023 | 4 | 2023 |
| Impact of vancomycin loading doses and dose escalation on glomerular function and kidney injury biomarkers in a translational rat model J Chang, GM Pais, PL Engel, P Klimek, S Marianski, K Valdez, ... Antimicrobial Agents and Chemotherapy 67 (2), e01276-22, 2023 | 4 | 2023 |
| Blood biomarkers and metabolomic profiling for the early diagnosis of vancomycin-associated acute kidney injury: a systematic review and meta-analysis of experimental studies E Laou, T Mavridis, N Papagiannakis, G Pais, A Chighine, J Chang, ... Journal of personalized medicine 12 (9), 1397, 2022 | 4 | 2022 |
| Does calculation method matter for targeting vancomycin area under the curve? J Chang, D Patel, A Vega, KC Claeys, EL Heil, MH Scheetz Journal of Antimicrobial Chemotherapy 77 (8), 2245-2250, 2022 | 3 | 2022 |
| Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring J Chang, J Liu, KS Kaye, MH Scheetz Clinical Infectious Diseases 73 (5), e1235-e1236, 2021 | 2 | 2021 |
| Past, present, and future biomarkers of kidney function and injury: the relationship with antibiotics J Chang, GM Pais, EF Barreto, B Young, H Scott, Z Schwartz, C Cartwright, ... International Journal of Antimicrobial Agents 64 (5), 107332, 2024 | 1 | 2024 |
| Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults J Chang, J Liu, MH Alshaer, V Venugopalan, N Maranchick, CA Peloquin, ... Journal of Antimicrobial Chemotherapy 78 (9), 2170-2174, 2023 | 1 | 2023 |
| Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model J Chang, GM Pais, S Marianski, K Valdez, E Lesnicki, EF Barreto, ... Antimicrobial Agents and Chemotherapy 67 (8), e00304-23, 2023 | 1 | 2023 |
| Vancomycin pharmacokinetics in a pregnancy rat model SN Avedissian, GM Pais, M Pham, J Liu, J Chang, K Hlukhenka, ... Antimicrobial Agents and Chemotherapy 66 (5), e00056-22, 2022 | 1 | 2022 |
Marc H. ScheetzProfessor of Pharmacy and Pharmacology, Midwestern University, Colleges of Pharmacy and GraduateBestätigte E-Mail-Adresse bei midwestern.edu